Cadrenal Therapeutics, Inc. Common Stock
CVKD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $28 | $24 | $33 | $22 |
| - Cash | $4 | $6 | $7 | $10 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $24 | $18 | $25 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$4 | -$4 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$4 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.31 | -1.87 | -2.09 | -2.75 |
| % Growth | 29.9% | 10.5% | 24% | – |
| Operating Cash Flow | -$2 | -$3 | -$5 | -$2 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$3 | -$5 | -$2 |